Winn Chatham

7.4k total citations · 1 hit paper
45 papers, 4.7k citations indexed

About

Winn Chatham is a scholar working on Rheumatology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Winn Chatham has authored 45 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Rheumatology, 22 papers in Immunology and 11 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Winn Chatham's work include Systemic Lupus Erythematosus Research (22 papers), T-cell and B-cell Immunology (13 papers) and Monoclonal and Polyclonal Antibodies Research (11 papers). Winn Chatham is often cited by papers focused on Systemic Lupus Erythematosus Research (22 papers), T-cell and B-cell Immunology (13 papers) and Monoclonal and Polyclonal Antibodies Research (11 papers). Winn Chatham collaborates with scholars based in United States, Canada and Czechia. Winn Chatham's co-authors include William Stohl, William W. Freimuth, Michelle Petri, Richard Furie, Z. John Zhong, Joan T. Merrill, Ellen M. Ginzler, Daniel J. Wallace, Robert P. Kimberly and Marc Chévrier and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and Annals of the Rheumatic Diseases.

In The Last Decade

Winn Chatham

43 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

2011 1.1k citations Richard Furie, Michelle Petri et al. Arthritis & Rheumatism profile →

Peers

Countries citing papers authored by Winn Chatham

Since Specialization

Citations

This map shows the geographic impact of Winn Chatham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Winn Chatham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Winn Chatham more than expected).

Fields of papers citing papers by Winn Chatham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Winn Chatham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Winn Chatham. The network helps show where Winn Chatham may publish in the future.

Co-authorship network of co-authors of Winn Chatham

This figure shows the co-authorship network connecting the top 25 collaborators of Winn Chatham. A scholar is included among the top collaborators of Winn Chatham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Winn Chatham. Winn Chatham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Implementation outcomes of a patient decision-aid in a diverse population with systemic lupus erythematosus in 15 US rheumatology clinics 2025 ·Lara D. Veeken ·Jasvinder A. Singh, Larry R. Hearld, Seth A. Eisen, Winn Chatham, Sonali Narain, Narender Annapureddy, (unknown), (unknown), Vikas Majithia, Cathy Lee Ching, (unknown), (unknown), Daniel J. Wallace, Rosalind Ramsey‐Goldman, Alfred H.J. Kim, Maureen McMahon, S. Sam Lim, (unknown), Alexa Meara, Kenneth Kalunian, Mark Beasley, (unknown), (unknown), (unknown), (unknown), Jackson, (unknown), (unknown), (unknown), (unknown), (unknown)	0
2	American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 2 2020 ·Arthritis & Rheumatology ·Ted R. Mikuls, Sindhu R. Johnson, Liana Fraenkel, Reuben J. Arasaratnam, Lindsey R. Baden, Bonnie L. Bermas, Winn Chatham, Stanley Cohen, Karen H. Costenbader, Ellen M. Gravallese, André C. Kalil, Michael E. Weinblatt, Kevin Winthrop, Amy S. Mudano, Amy S. Turner, Kenneth G. Saag	42
3	American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 3 2020 ·Arthritis & Rheumatology ·Ted R. Mikuls, Sindhu R. Johnson, Liana Fraenkel, Reuben J. Arasaratnam, Lindsey R. Baden, Bonnie L. Bermas, Winn Chatham, Stanley Cohen, Karen H. Costenbader, Ellen M. Gravallese, André C. Kalil, Michael E. Weinblatt, Kevin Winthrop, Amy S. Mudano, Amy S. Turner, Kenneth G. Saag	145
4	Safety and Efficacy of Belimumab Plus Standard Therapy for Up to Thirteen Years in Patients With Systemic Lupus Erythematosus 2019 ·Arthritis & Rheumatology ·Daniel J. Wallace, Ellen M. Ginzler, Joan T. Merrill, Richard Furie, William Stohl, Winn Chatham, Arthur Weinstein, James D. McKay, W. Joseph McCune, Michelle Petri, James Fettiplace, David A. Roth, Beulah Ji, Amy Heath	84
5	Barriers to Medication Decision Making in Women with Lupus Nephritis: A Formative Study using Nominal Group Technique 2015 ·The Journal of Rheumatology ·Jasvinder A. Singh, Haiyan Qu, Jinoos Yazdany, Winn Chatham, Maria Dall’Era, Richard M. Shewchuk	21
6	Vasculitis related to viral and other microbial agents 2015 ·Best Practice & Research Clinical Rheumatology ·Gim Gee Teng, Winn Chatham	22
7	Measurement of cell‐bound complement activation products enhances diagnostic performance in systemic lupus erythematosus 2012 ·Arthritis & Rheumatism ·Kenneth Kalunian, Winn Chatham, Elena Massarotti, (unknown), (unknown), Richard Furie, Puja Chitkara, Chaim Putterman, (unknown), Emily C. Somers, Kyriakos A. Kirou, Rosalind Ramsey‐Goldman, Christine Hsieh, Jill P. Buyon, Thierry Dervieux, Arthur Weinstein	62
8	Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus 2012 ·Arthritis & Rheumatism ·William Stohl, Falk Hiepe, Kevin Latinis, Mathew Thomas, Morton Scheinberg, Ann E. Clarke, Cynthia Aranow, (unknown), Carlos Abud‐Mendoza, Douglas R. Hough, Lilia Pineda, Thi‐Sau Migone, Z. John Zhong, William W. Freimuth, Winn Chatham, (unknown)	311
9	Effect of Belimumab on Vaccine Antigen Antibodies to Influenza, Pneumococcal, and Tetanus Vaccines in Patients with Systemic Lupus Erythematosus in the BLISS-76 Trial 2012 ·The Journal of Rheumatology ·Winn Chatham, Daniel J. Wallace, William Stohl, Kevin Latinis, Susan Manzi, W. Joseph McCune, Dana Tegzová, James D. McKay, (unknown), Tammy O. Utset, Z. John Zhong, Douglas R. Hough, William W. Freimuth, Thi-Sau Migone	66
10	B lymphocytes are resistant to death receptor 5-induced apoptosis 2011 ·Clinical Immunology ·(unknown), Hong Zhao, Winn Chatham, Tong Zhou, Robert H. Carter	5
11	Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity 2009 ·Journal of Clinical Investigation ·Hitoshi Suzuki, Run Fan, Zhixin Zhang, Rhubell Brown, Stacy Hall, Bruce A. Julian, Winn Chatham, Yusuke Suzuki, Robert Wyatt, Zina Moldoveanu, Jeannette Lee, James Robinson, Milan Tomana, Yasuhiko Tomino, Jiří Městecký, Jan Novák	341
12	Novel evidence‐based systemic lupus erythematosus responder index 2009 ·Arthritis Care & Research ·Richard Furie, Michelle Petri, Daniel J. Wallace, Ellen M. Ginzler, Joan T. Merrill, William Stohl, Winn Chatham, Vibeke Strand, Arthur Weinstein, Marc Chévrier, Z. John Zhong, William W. Freimuth	341
13	Rheumatic manifestations of systemic disease: sarcoidosis 2009 ·Current Opinion in Rheumatology ·Winn Chatham	27
14	Increased Expression of Activation‐Induced Cytidine Deaminase is Associated with Anti‐CCP and Rheumatoid Factor in Rheumatoid Arthritis 2009 ·Scandinavian Journal of Immunology ·Xin Xu, Hui‐Chen Hsu, (unknown), William E. Grizzle, Winn Chatham, Cecil R. Stockard, Qi Wu, PingAr Yang, V. Michael Holers, John D. Mountz	30
15	Ultrasound appearance of knuckle pads 2006 ·Skeletal Radiology ·Robert Lopez‐Ben, (unknown), Winn Chatham, Donald H. Lee, (unknown), Graciela S. Alarcón	10
16	Expression and occupancy of BAFF‐R on B cells in systemic lupus erythematosus 2005 ·Arthritis & Rheumatism ·Robert H. Carter, Hong Zhao, Ximeng Liu, Marc R. Pelletier, Winn Chatham, Robert P. Kimberly, Tong Zhou	85
17	Improving Ambulatory Prescribing Safety with a Handheld Decision Support System: A Randomized Controlled Trial 2005 ·Journal of the American Medical Informatics Association ·Eta S. Berner, T. K. Houston, (unknown), Jeroan J. Allison, Gustavo R. Heudebert, Winn Chatham, John I. Kennedy, Gerald L. Glandon, Peter J. Norton, Mike Crawford, (unknown)	63
18	FcγRIIIb Allele-Sensitive Release of α-Defensins: Anti-Neutrophil Cytoplasmic Antibody-Induced Release of Chemotaxins 2003 ·The Journal of Immunology ·Sumiaki Tanaka, Jeffrey C. Edberg, Winn Chatham, Giorgio Fassina, Robert P. Kimberly	23
19	Renal failure: A risk factor for methotrexate toxicity 2000 ·Arthritis & Rheumatism ·Winn Chatham, Sarah Morgan, Graciela S. Alarcón	21
20	Degradation of human articular cartilage by neutrophils in synovial fluid 1993 ·Arthritis & Rheumatism ·Winn Chatham, (unknown), (unknown), Louis W. Heck, Edward J. Miller, Warren D. Blackburn	76

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact